Literature DB >> 11809675

Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.

Benno Küsters1, William P J Leenders, Pieter Wesseling, Debby Smits, Kiek Verrijp, Dirk J Ruiter, Johannes P W Peters, Albert J van Der Kogel, Robert M W de Waal.   

Abstract

We investigated the mechanisms of vascularization in a brain metastases model of malignant melanoma. Parenchymal metastases expressing little vascular endothelial growth factor-A (VEGF-A) co-opted the preexistent brain vasculature, leading to an infiltrative phenotype. Metastases of the human melanoma cell line Mel57, engineered to express recombinant VEGF-A(165), showed accelerated growth in a combined expansive and infiltrative pattern with marked central necrosis. This difference in growth profile was accompanied by dilation of co-opted intra- and peritumoral vessels with concomitant induction of vascular permeability. Our data show that modulation of preexistent vasculature can contribute to malignant progression without induction of sprouting angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809675

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

Review 1.  The biology of brain metastases-translation to new therapies.

Authors:  April F Eichler; Euiheon Chung; David P Kodack; Jay S Loeffler; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2011-04-12       Impact factor: 66.675

Review 2.  Current approaches to the treatment of metastatic brain tumours.

Authors:  Taofeek K Owonikoko; Jack Arbiser; Amelia Zelnak; Hui-Kuo G Shu; Hyunsuk Shim; Adam M Robin; Steven N Kalkanis; Timothy G Whitsett; Bodour Salhia; Nhan L Tran; Timothy Ryken; Michael K Moore; Kathleen M Egan; Jeffrey J Olson
Journal:  Nat Rev Clin Oncol       Date:  2014-02-25       Impact factor: 66.675

3.  Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.

Authors:  L Tiffany Lyle; Paul R Lockman; Chris E Adkins; Afroz Shareef Mohammad; Emily Sechrest; Emily Hua; Diane Palmieri; David J Liewehr; Seth M Steinberg; Wojciech Kloc; Ewa Izycka-Swieszewska; Renata Duchnowska; Naema Nayyar; Priscilla K Brastianos; Patricia S Steeg; Brunilde Gril
Journal:  Clin Cancer Res       Date:  2016-05-31       Impact factor: 12.531

Review 4.  Divergent roles of Plexin D1 in cancer.

Authors:  Sneha Vivekanadhan; Debabrata Mukhopadhyay
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 5.  The brain metastatic niche.

Authors:  Frank Winkler
Journal:  J Mol Med (Berl)       Date:  2015-11       Impact factor: 4.599

Review 6.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

7.  Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas.

Authors:  Daniel Bexell; Salina Gunnarsson; Ariane Tormin; Anna Darabi; David Gisselsson; Laurent Roybon; Stefan Scheding; Johan Bengzon
Journal:  Mol Ther       Date:  2008-11-04       Impact factor: 11.454

Review 8.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

9.  Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.

Authors:  Iris Helfrich; Inka Scheffrahn; Sönke Bartling; Joachim Weis; Verena von Felbert; Mark Middleton; Masahi Kato; Süleyman Ergün; Helmut G Augustin; Dirk Schadendorf
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

10.  Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies.

Authors:  Ilse Roodink; Kiek Verrijp; Jos Raats; William P J Leenders
Journal:  BMC Cancer       Date:  2009-08-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.